Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AR 401 - Aimmune Therapeutics

Next Previous
Drug Profile

AR 401 - Aimmune Therapeutics

Alternative Names: AR 401 - food allergy OIT - Aimmune Therapeutics; AR 401 - food allergy oral immunotherapies - Aimmune Therapeutics; AR-401 - Aimmune Therapeutics; Multi-tree nut allergy - Aimmune Therapeutics

Latest Information Update: 28 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aimmune Therapeutics
  • Class Allergens; Antiallergics; Food allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Food hypersensitivity

Most Recent Events

  • 28 Aug 2024 No recent reports of development identified for preclinical development in Food-hypersensitivity in USA (PO)
  • 14 Oct 2020 Aimmune Therapeutics has been acquired by Nestle
  • 05 Aug 2020 Aimmune Therapeutics announces intention to submit IND application to the US FDA for Food hypersensitivity (Multi tree nut allergy) (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top